| RS1243716539 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1243721108 |
COQ8A
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS1243748540 |
DLL3
|
Health Risk |
Pathogenic |
— |
| RS1243753206 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1243762658 |
TENM3
|
Health Risk |
Likely pathogenic |
Microphthalmia, isolated |
| RS1243776150 |
PNPT1
|
Health Risk |
Likely pathogenic |
— |
| RS1243779049 |
HADHA
|
Health Risk |
Pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS1243845978 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4A |
| RS1243847782 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1243863645 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS1243868138 |
KCNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 32 |
| RS1243886871 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1243898549 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1243918665 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS1243920034 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1243923870 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1243948503 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1243952083 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS1243965664 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1243971835 |
ACAD9
|
Health Risk |
Pathogenic |
— |
| RS1243977956 |
GABRA2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 78 |
| RS1243985803 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1243997625 |
SIK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 30 |
| RS1243999036 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS1244003380 |
CHM
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Choroideremia |
| RS1244011928 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1244017657 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1244029486 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1244049089 |
VPS41
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive 29 |
| RS1244049824 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1244056899 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1244058062 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 4 |
| RS1244071473 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS1244074570 |
ERCC5
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum, group G |
| RS1244082467 |
JPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1244093431 |
TEX15
|
Health Risk |
Pathogenic |
Spermatogenic failure 25, Spermatogenic failure 25 |
| RS1244097151 |
APRT
|
Health Risk |
Likely pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1244103739 |
PIGO
|
Health Risk |
Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1244119341 |
CPLANE1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS1244121412 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS1244128314 |
OCA2
|
Health Risk |
Likely pathogenic |
— |
| RS1244139989 |
VPS13A
|
Health Risk |
Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1244142295 |
DNHD1
|
Health Risk |
Likely pathogenic |
— |
| RS1244151760 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1244153418 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, ABCB11-related disorder |
| RS1244155207 |
BSCL2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1244156082 |
SKIC2
|
Health Risk |
Likely pathogenic |
Trichohepatoenteric syndrome, Trichohepatoenteric syndrome |
| RS1244161898 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1244167364 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Medulloblastoma |
| RS1244170961 |
TTC21B
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS1244173581 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1244178555 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1244188050 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS1244221685 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1244226820 |
TIMM50
|
Health Risk |
Likely pathogenic |
3-methylglutaconic aciduria type 9, 3-methylglutaconic aciduria type 9 |
| RS1244227519 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1244240617 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1244241099 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS1244255905 |
PRRT2
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia, Episodic kinesigenic dyskinesia |
| RS1244264430 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Potassium-aggravated myotonia |
| RS1244267880 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1244284678 |
SOCS1
|
Health Risk |
Pathogenic |
AUTOINFLAMMATORY SYNDROME, FAMILIAL |
| RS1244303575 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1244303801 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1244307754 |
MKS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 13, Meckel syndrome |
| RS1244315984 |
WDR87
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1244318419 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1244339215 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 1A (Zellweger), Peroxisome biogenesis disorder |
| RS1244342890 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1244369953 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS1244378437 |
USH1C
|
Health Risk |
Pathogenic |
— |
| RS1244404381 |
GLB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-B |
| RS1244415676 |
GPR179
|
Health Risk |
Pathogenic |
— |
| RS1244436929 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 2, Ullrich congenital muscular dystrophy 2 |
| RS1244442256 |
BBS5
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1244471687 |
PEX16
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS1244476467 |
CPAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1244506651 |
FREM1
|
Health Risk |
Likely pathogenic |
— |
| RS1244507563 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS1244511121 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS1244511644 |
NMNAT1
|
Health Risk |
Likely pathogenic |
— |
| RS1244531716 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome, Lynch syndrome |
| RS1244537662 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1244562984 |
SETD1B
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with seizures and language delay, Intellectual developmental disorder with seizures and language delay |
| RS1244609956 |
NEMF
|
Health Risk |
Likely pathogenic |
— |
| RS1244633595 |
MPV17
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1244655820 |
NAGLU
|
Health Risk |
Pathogenic/Likely pathogenic |
Sanfilippo syndrome, Mucopolysaccharidosis |
| RS1244656046 |
CPLANE1
|
Health Risk |
Likely pathogenic |
— |
| RS1244671706 |
BEST1
|
Health Risk |
Pathogenic |
— |
| RS1244688796 |
KCNE1
|
Health Risk |
Pathogenic |
Jervell and Lange-Nielsen syndrome 2, Long QT syndrome |
| RS1244691285 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS1244718647 |
ARSG
|
Health Risk |
Pathogenic |
Usher syndrome, type 4 |
| RS1244721341 |
SPAG1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia |
| RS1244721977 |
TTC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 8 |
| RS1244732832 |
STXBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Multiple congenital anomalies/dysmorphic syndrome |
| RS1244752544 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1244761864 |
LRP5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Retinal dystrophy |
| RS1244772203 |
USP7
|
Health Risk |
Likely pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS1244812690 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1244822375 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |